[ad_1]
Dr. Valeriu Gheorghiță, coordinator of the national vaccination campaign, said on Friday that it is “almost impossible” to establish a causal link between the AstraZeneca vaccine and the occurrence of thrombosis after immunization, given that only 13 cases were reported in 20 millions of Europeans vaccinated. He also stated that anticoagulant treatment is not recommended before vaccination. At the same time, he specified which symptoms those who were immunized with this serum should pay attention to.
“At this time, preventive treatment with anticoagulants is not recommended. Based on data centralized by the European Medicines Agency, we are talking about about 13 cases of venous cerebral sinus thrombosis, which means that out of 20 million people vaccinated in Europe and the United Kingdom, it is almost impossible to establish a causal link between vaccination, vaccination and the occurrence of these extremely rare phenomena.
For this reason, in the recommendations and precautions that will be mentioned in the leaflet, I believe that the most important thing is to send people what are the possible warning signs that will determine them to request a medical consultation after vaccination.
We are talking about extremely rare situations, that is, 3, 4, 5 cases per million vaccinated people. Given that we are in the middle of a pandemic and we know very well that we have a large number of asymptomatic cases and that this Sars-CoV-2 infection develops with a prothrombotic state, it is very difficult to say what is the level of risk of developing these events thrombotics in the current population, in a pandemic context and what is the contribution, if any, of the vaccine.
Caution and caution are advised for certain symptoms, such as a headache that persists, begins at least 3 days after vaccination, and is not controlled with regular treatment. Then the person must go to a medical service. In general, it seems that this syndrome is developing, which would occur between 4 and 14 days from the time of vaccination, without a proven causal relationship at this time.
It is absolutely normal to continue investigating and promoting the monitoring and reporting of all adverse reactions, precisely because we are talking about two peculiarities: a pandemic in which the Sars-CoV-2 infection progresses, in many cases, at least 30-40 %. of the cases, asymptomatic and causes a prothrombotic state; we are talking about millions of people vaccinated.
Such a vaccination campaign has never happened before, so we can deal with extremely rare events, which, at this time, it is impossible to link or exclude from vaccination, ”said Valeriu Gheorghiță, at Digi24.
More than 380,000 places are occupied for vaccination with AstraZeneca serum
He also said that almost 80,000 immunization appointments with the Oxford-AstraZeneca vaccine against Covid-19 have been canceled since the beginning of the period in which possible problems were reported, but that there are more than 380,000 people on the scheduled platform in the centers where to administer. this vaccine.
“Approximately 80,000 cancellations from the platform, but at the same time there were many appointments, so, at this moment, there are more than 380,000 occupied places on the platform in the centers where the vaccine is distributed from AstraZeneca. Of these places, approximately 125,000 people are for dose I.
I think what has happened in the last 24 hours is more relevant. There were around 12,500 cancellations and, at the same time, some 14,000 new appointments were made. The situation that I asked my colleagues at STS was from 1:00 p.m., so it somehow includes the period before the announcement made by the European Medicines Agency.
The number of those who schedule is greater than that of those who cancel their appointments. An important fact to mention, this weekend the programming platform will begin to notify people on the waiting list of the places that will be made available after the cancellation of appointments, to notify other people who are on the waiting list and who may want to occupy that free. place in a vaccination center.
I am convinced, at this point, that there is a doubt among the population and perhaps a certain degree of mistrust in the safety of this type of vaccine. I believe that together with my colleagues, through communication and information as often as possible about the benefits and risks, we can gradually increase the confidence in this type of vaccine, because we really need to take into account the scientific data that proves that this vaccine remains safe and effective, ”said the coordinator of the national immunization campaign against Covid-19.
Editing: Alexandru Costea
